The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Breast cancer statistics, 2011
Open accessAbstract
In this article, the American Cancer Society provides an overview of female breast cancer statistics in the United States, including trends in incidence, mortality, survival, and screening. Approximately 230,480 new cases of invasive breast cancer and 39,520 breast cancer deaths are expected to occur among US women in 2011. Breast cancer incidence rates were stable among all racial/ethnic groups from 2004 to 2008. Breast cancer death rates have been declining since the early 1990s for all women except American Indians/Alaska Natives, among whom rates have remained stable. Disparities in breast cancer death rates are evident by state, socioeconomic status, and race/ethnicity. While significant declines in mortality rates were observed for 36 states and the District of Columbia over the past 10 years, rates for 14 states remained level. Analyses by county‐level poverty rates showed that the decrease in mortality rates began later and was slower among women residing in poor areas. As a result, the highest breast cancer death rates shifted from the affluent areas to the poor areas in the early 1990s. Screening rates continue to be lower in poor women compared with non‐poor women, despite much progress in increasing mammography utilization. In 2008, 51.4% of poor women had undergone a screening mammogram in the past 2 years compared with 72.8% of non‐poor women. Encouraging patients aged 40 years and older to have annual mammography and a clinical breast examination is the single most important step that clinicians can take to reduce suffering and death from breast cancer. Clinicians should also ensure that patients at high risk of breast cancer are identified and offered appropriate screening and follow‐up. Continued progress in the control of breast cancer will require sustained and increased efforts to provide high‐quality screening, diagnosis, and treatment to all segments of the population. CA Cancer J Clin 2011;. © 2011 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,781
Siegel, R., Ward, E., Brawley, O., & Jemal, A. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20121 · Cited by 4,070
Self-citationRace, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study
Carey, L. A., Perou, C. M., Livasy, C. A., Dressler, L. G., Cowan, D., Conway, K., Karaca, G., Troester, M. A., Tse, C. K., Edmiston, S., et al. (2006) · JAMA · doi:10.1001/jama.295.21.2492 · Cited by 3,819
Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer
Berry, D. A., Cronin, K. A., Plevritis, S. K., Fryback, D. G., Clarke, L., Zelen, M., Mandelblatt, J. S., Yakovlev, A. Y., Habbema, J. D. F., & Feuer, E. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050518 · Cited by 2,460
The Decrease in Breast-Cancer Incidence in 2003 in the United States
Ravdin, P. M., Cronin, K. A., Howlader, N., Berg, C. D., Chlebowski, R. T., Feuer, E. J., Edwards, B. K., & Berry, D. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmsr070105 · Cited by 982
McGuire, S. (2011) · Advances in Nutrition · doi:10.3945/an.111.000497 · Cited by 694
Ethnicity and Breast Cancer: Factors Influencing Differences in Incidence and Outcome
Chlebowski, R. T., Chen, Z., Anderson, G. L., Rohan, T., Aragaki, A., Lane, D., Dolan, N. C., Paskett, E. D., McTiernan, A., Hubbell, F. A., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji064 · Cited by 656
Reproductive History and Oral Contraceptive Use in Relation to Risk of Triple-Negative Breast Cancer
Phipps, A. I., Chlebowski, R. T., Prentice, R., McTiernan, A., Wactawski-Wende, J., Kuller, L. H., Adams-Campbell, L. L., Lane, D., Stefanick, M. L., Vitolins, M., et al. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr030 · Cited by 248
Gwyn, K., Bondy, M. L., Cohen, D. S., Lund, M. J., Liff, J. M., Flagg, E. W., Brinton, L. A., Eley, J. W., & Coates, R. J. (2004) · Cancer · doi:10.1002/cncr.20169 · Cited by 210
Cited by
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Self-citationSiegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
Self-citationSiegel, R. L., Miller, K. D., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21254 · Cited by 11,853
Self-citationMa, J., & Jemal, A. (2013) · Breast Cancer Metastasis and Drug Resistance · doi:10.1007/978-1-4614-5647-6_1 · Cited by 1,907
Self-citationZhang, C., Samanta, D., Lu, H., Bullen, J. W., Zhang, H., Chen, I., He, X., & Semenza, G. L. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602883113 · Cited by 971
Breast cancer as a systemic disease: a view of metastasis
Redig, A. J., & McAllister, S. S. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12084 · Cited by 709
Breast Cancer: Epidemiology and Etiology
Tao, Z., Shi, A., Lu, C., Song, T., Zhang, Z., & Zhao, J. (2015) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-014-0459-6 · Cited by 699
Cancer statistics for Hispanics/Latinos, 2012
Siegel, R., Naishadham, D., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21153 · Cited by 655
Self-citationCruz-Roa, A., Basavanhally, A., González, F., Gilmore, H., Feldman, M., Ganesan, S., Shih, N., Tomaszewski, J., & Madabhushi, A. (2014) · SPIE Proceedings · doi:10.1117/12.2043872 · Cited by 573
Cruz-Roa, A., Gilmore, H., Basavanhally, A., Feldman, M., Ganesan, S., Shih, N. N. C., Tomaszewski, J., González, F. A., & Madabhushi, A. (2017) · Scientific Reports · doi:10.1038/srep46450 · Cited by 532
Resveratrol and cancer: focus on in vivo evidence
Carter, L. G., D'Orazio, J. A., & Pearson, K. J. (2014) · Endocrine-Related Cancer · doi:10.1530/erc-13-0171 · Cited by 522
DNA Methyltransferases: A Novel Target for Prevention and Therapy
Subramaniam, D., Thombre, R., Dhar, A., & Anant, S. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00080 · Cited by 476
Health-related quality of life in breast cancer patients: review of reviews from 2008 to 2018
Mokhtari-Hessari, P., & Montazeri, A. (2020) · Health and Quality of Life Outcomes · doi:10.1186/s12955-020-01591-x · Cited by 437
Breast cancer in India: Present scenario and the challenges ahead
Mehrotra, R., & Yadav, K. (2022) · World Journal of Clinical Oncology · doi:10.5306/wjco.v13.i3.209 · Cited by 376
Effects of Age on the Detection and Management of Breast Cancer
McGuire, A., Brown, J., Malone, C., McLaughlin, R., & Kerin, M. (2015) · Cancers · doi:10.3390/cancers7020815 · Cited by 374
Mesenchymal–epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer
Gunasinghe, N. P. A. D., Wells, A., Thompson, E. W., & Hugo, H. J. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9377-5 · Cited by 339
Wahab, R., Siddiqui, M. A., Saquib, Q., Dwivedi, S., Ahmad, J., Musarrat, J., Al-Khedhairy, A. A., & Shin, H.-S. (2014) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2014.02.038 · Cited by 331
Breast Cancer Statistics: Recent Trends
Ahmad, A. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-20301-6_1 · Cited by 308
Epidemiology and prognosis of breast cancer in young women.
Assi, H., Khoury, K. E., Dbouk, H., Khalil, L. E., Mouhieddine, T. H., & Saghir, N. S. E. (2013) · PubMed · doi:10.3978/j.issn.2072-1439.2013.05.24 · Cited by 306
Gilbert, C. A., & Slingerland, J. M. (2013) · Annual Review of Medicine · doi:10.1146/annurev-med-121211-091527 · Cited by 302
Kim, S.-Y., Kang, J. W., Song, X., Kim, B. K., Yoo, Y. D., Kwon, Y. T., & Lee, Y. J. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.01.007 · Cited by 297
Optimal Expectations and Limited Medical Testing: Evidence from Huntington Disease
Oster, E., Shoulson, I., & Dorsey, E. R. (2013) · American Economic Review · doi:10.1257/aer.103.2.804 · Cited by 290
Targeting AKT for cancer therapy
Shariati, M., & Meric-Bernstam, F. (2019) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2019.1676726 · Cited by 290
Tumor-associated macrophages as potential diagnostic and prognostic biomarkers in breast cancer
Tang, X. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.01.024 · Cited by 276
Gold nanoparticles in breast cancer treatment: Promise and potential pitfalls
Lee, J., Chatterjee, D. K., Lee, M. H., & Krishnan, S. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.02.006 · Cited by 271
Decision tree classifiers for automated medical diagnosis
Azar, A. T., & El-Metwally, S. M. (2013) · Neural Computing and Applications · doi:10.1007/s00521-012-1196-7 · Cited by 242
Soy, Red Clover, and Isoflavones and Breast Cancer: A Systematic Review
Fritz, H., Seely, D., Flower, G., Skidmore, B., Fernandes, R., Vadeboncoeur, S., Kennedy, D., Cooley, K., Wong, R., Sagar, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081968 · Cited by 188
HIC1 and miR-23~27~24 clusters form a double-negative feedback loop in breast cancer
Wang, Y., Liang, H., Zhou, G., Hu, X., Liu, Z., Jin, F., Yu, M., Sang, J., Zhou, Y., Fu, Z., et al. (2017) · Cell Death & Differentiation · doi:10.1038/cdd.2016.136 · Cited by 38
Metadata
- Authors
- DeSantis, C., Siegel, R., Bandi, P., & Jemal, A.
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 2011-10-03
- Volume
- 61
- Issue
- 6
- Pages
- 408-418
- ISSN
- 0007-9235 (ISSN-L)
- 1542-4863
- OpenAlex
- W2917423152
- Cited by
- 1,326
- References
- 18
- FWCI
- 59.01
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.